Login

Nicolas Schweizer, CEO of Schweitzer Electronic, envisions a thriving future for the PCB industry in Europe. 00:10:00

Share On Facebook Share On Twitter

Nicolas Schweizer, CEO of Schweitzer Electronic

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Evolution of Connectivity: From Web 1.0 to 3.0 with Hybrid Networks Simplified | Donald Bugos , CEO of Communication Systems, Inc.
00:00:00
Christian Hoyer Millar, CEO, Oxford Biodynamics P
00:10:00
Key Benefits and Considerations of Outsourcing in Banking
00:10:00
Maximizing Your Stock Options: Strategic Insights from Robbie Schoonmaker | Matterhorn Financial Planning
00:10:00
Embracing the synergy of technology and values to propel towards a sustainable future, as articulated |Robert Itschner, CEO, BKW AG.
00:00:00
Orthocell raising $3.5 million; adds heavy hitters to register - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:10:00
Haley Barbour on Mississippi Politics and the Republican Transformation
00:10:00
Max Boot on the History and Importance of Guerrilla Warfare
00:10:00
Fortress Builders: The Rise of the Cybersecurity Entrepreneur|Zane Lackey,General Partner,Andreessen Horowitz
00:10:00
Ben Hockema and Eddie Arraya Review 2023 Investment Markets: Fed Policy, Higher Yields, and Long-Term Returns | Ben Hockema, Founder, Illuminate Wealth Management.
00:10:00
Sam Garrett Shares Promising Copper-Gold Findings from Especularita’s Victoria Prospect | Sam Garrett, CEO, Great Southern Copper PLC.
00:10:00
Unlocking Savings: How to Lower Your Auto Insurance Rates | John Smith, Insurance Specialist, ABC Insurance Agency

© 2026 Nehu